A Fusion Protein Complex that Combines IL-12, IL-15, and IL-18 Signaling to Induce Memory-Like NK Cells for Cancer Immunotherapy

被引:42
|
作者
Becker-Hapak, Michelle K. [1 ]
Shrestha, Niraj [2 ]
McClain, Ethan [1 ]
Dee, Michael J. [2 ]
Chaturvedi, Pallavi [2 ]
Leclerc, Gilles M. [2 ]
Marsala, Lynne I. [1 ]
Foster, Mark [1 ]
Schappe, Timothy [1 ]
Tran, Jennifer [1 ]
Desai, Sweta [1 ]
Neal, Carly C. [1 ]
Pence, Patrick [1 ]
Wong, Pamela [1 ]
Wagner, Julia A. [1 ]
Russler-Germain, David A. [1 ]
Zhu, Xiaoyun [2 ]
Spanoudis, Catherine M. [2 ]
Gallo, Victor L. [2 ]
Echeverri, Christian A. [2 ]
Ramirez, Laritza L. [2 ]
You, Lijing [2 ]
Egan, Jack O. [2 ]
Rhode, Peter R. [2 ]
Jiao, Jin-an [2 ]
Muniz, Gabriela J. [2 ]
Jeng, Emily K. [2 ]
Prendes, Caitlin A. [2 ]
Sullivan, Ryan P. [3 ]
Berrien-Elliott, Melissa M. [1 ]
Wong, Hing C. [2 ]
Fehniger, Todd A. [1 ]
机构
[1] Washington Univ, Sch Med, Div Oncol, St Louis, MO USA
[2] HCW Biol Inc, Miramar, FL USA
[3] Wugen Inc, St Louis, MO USA
关键词
NATURAL-KILLER-CELLS; GENE-EXPRESSION; TISSUE FACTOR; CYTOKINE; RECEPTOR; SUPERAGONIST; METHYLATION; ACTIVATION; EFFICACY; PACKAGE;
D O I
10.1158/2326-6066.CIR-20-1002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Natural killer (NK) cells arc a promising cellular therapy for cancer, with challenges in the field including persistence, functional activity, and tumor recognition. Briefly, priming blood NK cells with recombinant human (rh)IL-12, rh I L-15, and rhIL-18 (12/15/18) results in memory-like NK cell differentiation and enhanced responses against cancer. However, the lack of available, scalable Good Manufacturing Process (GMP)-grade reagents required to advance this approach beyond early-phase clinical trials is limiting. To address this challenge, we developed a novel platform centered upon an inert tissue factor scaffold for production of heteromeric fusion protein complexes (HFPC). The first use of this platform combined IL-12, IL-15, and IL-18 receptor engagement (HCW9201), and the second adds CD16 engagement (HCW9207). This unique HFPC expression platform was scalable with equivalent protein quality characteristics in small- and GMP-scale production. HCW9201 and HCW9207 stimulated activation and proliferation signals in NK cells, but HCW9207 had decreased IL-18 receptor signaling. RNA sequencing and multidimensional mass cytometry revealed parallels between HCW9201 and 12/15/18. HCW9201 stimulation improved NK cell metabolic fitness and resulted in the DNA methylation remodeling characteristic of memory-like differentiation. HCW9201 and 12/15/18 primed similar increases in short-term and memory-like NK cell cytotoxicity and IFNy production against leukemia targets, as well as equivalent control of leukemia in NSG mice. Thus, HFPCs represent a protein engineering approach that solves many problems associated with multisigna I receptor engagement on immune cells, and HCW9201-primed NK cells can be advanced as an ideal approach for clinical GMP-grade memory-like NK cell production for cancer therapy.
引用
收藏
页码:1071 / 1087
页数:17
相关论文
共 50 条
  • [1] A novel fusion protein scaffold 18/12/TxM activates the IL-12, IL-15, and IL-18 receptors to induce human memory-like natural killer cells
    Cubitt, Celia C.
    McClain, Ethan
    Becker-Hapak, Michelle
    Foltz, Jennifer A.
    Wong, Pamela
    Wagner, Julia A.
    Neal, Carly C.
    Marin, Nancy D.
    Marsala, Lynne
    Foster, Mark
    Schappe, Timothy
    Soon-Shiong, Patrick
    Lee, John
    Berrien-Elliott, Melissa M.
    Fehniger, Todd A.
    MOLECULAR THERAPY-ONCOLYTICS, 2022, 24 : 585 - 596
  • [2] IL-12 regulates the expansion, phenotype, and function of murine NK cells activated by IL-15 and IL-18
    Oka, Naoto
    Markova, Tzvetanka
    Tsuzuki, Kenzo
    Li, Wen
    El-Darawish, Yosif
    Pencheva-Demireva, Magdalena
    Yamanishi, Kyousuke
    Yamanishi, Hiromichi
    Sakagami, Masafumi
    Tanaka, Yoshimasa
    Okamura, Haruki
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2020, 69 (09) : 1699 - 1712
  • [3] Preactivation with IL-12, IL-15, and IL-18 Induces CD25 and a Functional High-Affinity IL-2 Receptor on Human Cytokine-Induced Memory-like Natural Killer Cells
    Leong, Jeffrey W.
    Chase, Julie M.
    Romee, Rizwan
    Schneider, Stephanie E.
    Sullivan, Ryan P.
    Cooper, Megan A.
    Fehniger, Todd A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (04) : 463 - 473
  • [4] IL-15 signaling in NK cell cancer immunotherapy
    Rautela, Jai
    Huntington, Nicholas D.
    CURRENT OPINION IN IMMUNOLOGY, 2017, 44 : 1 - 6
  • [5] Dendritic cells Trigger IFN-γ secretion by NK cells independent of IL-12 and IL-18
    Abdi, Kaveh
    Laky, Karen
    Abshari, Mehrnoosh
    Hill, Elizabeth M.
    Lantz, Larry
    Singh, Nevil J.
    Long, Eric O.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2022, 52 (09) : 1431 - 1440
  • [6] IL-18/IL-15/IL-12 synergy induces elevated and prolonged IFN-γ production by ex vivo expanded NK cells which is not due to enhanced STAT4 activation
    Lusty, Evan
    Poznanski, Sophie M.
    Kwofie, Karen
    Mandur, Talveer S.
    Lee, Dean A.
    Richards, Carl D.
    Ashkar, Ali A.
    MOLECULAR IMMUNOLOGY, 2017, 88 : 138 - 147
  • [7] Plasmodium falciparum-Infected Erythrocytes and IL-12/IL-18 Induce Diverse Transcriptomes in Human NK Cells: IFN-α/β Pathway versus TREM Signaling
    de Carvalho, Elisandra Grangeiro
    Bonin, Michael
    Kremsner, Peter G.
    Kun, Juergen F. J.
    PLOS ONE, 2011, 6 (09):
  • [8] IL-12, IL-15, and IL-18 pre-activated NK cells target resistant T cell acute lymphoblastic leukemia and delay leukemia development in vivo
    Boieri, Margherita
    Ulvmoen, Aina
    Sudworth, Amanda
    Lendrem, Clare
    Collin, Matthew
    Dickinson, Anne M.
    Kveberg, Lise
    Inngjerdingen, Marit
    ONCOIMMUNOLOGY, 2017, 6 (03):
  • [9] IL-15 Promotes Polyfunctional NK Cell Responses to Influenza by Boosting IL-12 Production
    Wagstaffe, Helen R.
    Nielsen, Carolyn M.
    Riley, Eleanor M.
    Goodier, Martin R.
    JOURNAL OF IMMUNOLOGY, 2018, 200 (08) : 2738 - 2747
  • [10] NK-92 cells change their phenotype and function when cocultured with IL-15, IL-18 and trophoblast cells
    Mikhailova, Valentina
    Khokhlova, Evgeniia
    Grebenkina, Polina
    Salloum, Zeina
    Nikolaenkov, Igor
    Markova, Kseniya
    Davidova, Alina
    Selkov, Sergey
    Sokolov, Dmitriy
    IMMUNOBIOLOGY, 2021, 226 (05)